⚠ Evidence warning: Clinical trials or other evidence do not support the claim that Schisandra raises VO2 max 3-7%, cuts lactate 15-30% and creatine kinase 20-40%, improves the cortisol-to-testosterone ratio and restored night vision in Soviet trials. This page keeps it as a report of what people, websites or other media say.
Schisandra for Endurance and Recovery
The endurance and physical-recovery research on Schisandra is one of the oldest and most operationally documented bodies of evidence on any adaptogen. Soviet sport-science institutes at Leningrad (now St. Petersburg), Moscow, and Vladivostok ran trials on cross-country skiers, gymnasts, weightlifters, military pentathletes, and special-forces personnel from the late 1950s through the 1980s, documenting reductions in blood lactate at standardized workloads, improved performance in graded exercise tests, and reduced recovery time between exercise sessions. Earlier than the Soviet institutional trials, anecdotal accounts from indigenous Nanai hunters and fishermen of the Russian Far East had long used fresh Schisandra berries to extend hunting and fishing endurance and to improve night vision. The mechanism combines glycogen-sparing oxidative-stress reduction, lactate-clearance improvement via mitochondrial-function preservation, cortisol-to-testosterone ratio modulation that favors anabolic recovery, and the broader adaptogenic stress-protein response covered in the Adaptogenic and Stress deep-dive.
Table of Contents
- The Nanai Hunters and Russian Far East Anecdotal Use
- Soviet Athletic and Military Endurance Research (1950s-1980s)
- Leningrad Institute of Physical Culture Trials
- Lactate Reduction and Mitochondrial Function
- What the 2008 Panossian and Wikman Review Reports
- Creatine Kinase and Skeletal Muscle Damage Markers
- Cortisol-to-Testosterone Ratio and Anabolic Recovery
- VO2 Max, Work Capacity, and Time-to-Exhaustion
- Contemporary Applications for Athletes and Active Adults
- Cautions and Practical Dosing for Athletic Use
- Modern Placebo-Controlled Trials in People
- Key Research Papers
- Connections
- Featured Videos
The Nanai Hunters and Russian Far East Anecdotal Use
The earliest documented use of Schisandra for physical endurance comes not from formal research but from ethnographic accounts of the indigenous Nanai people of the Russian Far East (the Khabarovsk Krai and Primorsky Krai regions north of Vladivostok along the Amur River basin). Nanai hunters and fishermen routinely carried small leather pouches of dried Schisandra berries on extended hunting expeditions into the taiga forest. The traditional report, recorded by Soviet ethnographers in the early 20th century:
- A small handful of dried berries (roughly 10-20 berries, providing perhaps 5-10 grams of dried fruit) consumed at the start of a hunt would allow a hunter to track game continuously through the day without food
- The berries were specifically reported to improve night vision and to allow tracking by faint trail signs in low light
- A second dose taken late in the day extended endurance for night travel
- Fresh berries were preferred when available; dried berries were reserved for winter use
This indigenous use pattern came to the attention of Soviet ethnographers and pharmacologists in the 1920s and 1930s. The Vladivostok Pharmaceutical Institute and later the Vladivostok branch of the All-Union Pharmaceutical Chemistry Institute conducted some of the first formal pharmacological investigations of Schisandra in the late 1930s and 1940s, initially specifically with the hypothesis of validating or refuting the Nanai endurance claims. The early Soviet animal studies confirmed measurable improvement in swim-to-exhaustion time and run-to-exhaustion time in laboratory rodents given Schisandra extract, providing the foundational evidence base that justified the much larger institutional research program described in subsequent sections.
The "improved night vision" claim is particularly interesting. Schisandra contains substantial concentrations of vitamin C and other water-soluble antioxidants in the fresh fruit, but the night-vision effect described by Nanai hunters likely also reflects general adaptogenic and visual-fatigue-reduction effects rather than a specific retinal photoreceptor effect. The claim is supported by Soviet trials in night-watch military personnel and submarine crew tested on dark-adaptation curves and Snellen low-luminance acuity, with modest improvements documented but never to a magnitude that would be clinically meaningful for diagnostic ophthalmology.
Soviet Athletic and Military Endurance Research (1950s-1980s)
The Soviet research program on Schisandra endurance applications ran for roughly thirty years from the late 1950s through the dissolution of the USSR in 1991. The institutional architecture involved several research centers:
- All-Union Pharmaceutical Chemistry Institute (Moscow / Vladivostok) — led by Nikolai Lazarev and later Israel Brekhman; provided the basic pharmacology, animal-model work, and adaptogen classification framework
- Leningrad Institute of Physical Culture (now Lesgaft National State University of Physical Culture) — the dominant venue for athletic performance trials; conducted trials on cross-country skiing, weightlifting, gymnastics, and wrestling teams competing at national and international levels
- Moscow Central Institute of Physical Culture — parallel athletic research focusing on track and field events and the military pentathlon
- Soviet Ministry of Defense research institutes — classified military trials on cosmonaut training, special-forces operations, submarine deployment endurance, and Arctic military operations; most of this work was published only in summary form or remained classified
- Far East Scientific Center of the USSR Academy of Sciences (Vladivostok) — under Brekhman, integrated the Schisandra, Eleuthero, and Rhodiola research programs
The published Soviet trial base in athletic performance includes literally hundreds of studies, most in Russian-language journals such as Lekarstvennye Sredstva Dal'nego Vostoka, Voprosy Pitaniya, and Fiziologicheskii Zhurnal SSSR Imeni I. M. Sechenova. Panossian and Wikman's 2008 English-language review sums up this work in one line: in healthy people, Schizandra “increases endurance and accuracy of movement, mental performance and working capacity.” The review's summary gives no effect sizes. The more detailed effects credited to the Soviet trials are:
- Reduction in blood lactate accumulation at standardized submaximal workloads
- Improvement in time-to-exhaustion at fixed workload
- Improvement in VO2 max in trained athletes
- Reduction in heart rate at standardized workloads (improved cardiovascular efficiency)
- Reduction in subjective rating of perceived exertion (RPE) at standardized workloads
- Reduction in post-exercise muscle soreness and creatine kinase elevation
- Acceleration of recovery between training sessions, allowing higher weekly training volume
One of these athlete studies is indexed in PubMed. In a placebo-controlled, double-blind study published in 1999, Panossian and colleagues gave standardized extracts of Schizandra chinensis and of Bryonia alba root to several groups of athletes. Physical performance was higher in the athletes taking the adaptogens than in those taking placebo. After treatment, heavy exercise no longer raised nitric oxide and cortisol in the saliva of the athletes taking the adaptogens, while heavy exercise still raised salivary nitric oxide in the athletes taking placebo.
The Soviet trials by modern standards have important methodological limitations: variable randomization quality, often inadequate blinding (the bitter, astringent taste of Schisandra extract makes placebo-matching difficult), small sample sizes typical of pre-1990 sport-science trials, and incomplete reporting of methods. Despite these limitations, the consistency of effects across many independent trials in different sports and different operational settings provides a substantial cumulative evidence base.
Leningrad Institute of Physical Culture Trials
The Leningrad Institute trials are the best-documented subset of the Soviet athletic research because several of the senior investigators (including Panossian after his post-1991 relocation to Sweden) subsequently summarized them in English-language reviews. A representative example from this body of work:
Accounts of this work describe a cross-country skiing trial at the Leningrad Institute in the late 1970s, in which elite skiers are said to have completed a 15-km time trial about 2-3% faster 60 minutes after a dose of Schisandra tincture than in a baseline session. No published report of this trial could be found, so its design and figures cannot be checked.
The same accounts describe parallel trials in weightlifting (Soviet weightlifters were a dominant force in Olympic competition through the 1980s) documented improvements in time-to-exhaustion at submaximal loads (e.g., bench-press repetitions at 70% of one-rep maximum) and reduction in creatine kinase elevation 24-48 hours post-training, consistent with reduced muscle damage and accelerated recovery. Gymnastics trials focused on cognitive-motor performance under fatigue, with improvements in beam-routine error rates after a standardized fatigue protocol. These trials, too, could not be traced to a published paper.
The Soviet sport-science conclusion by the early 1980s was that Schisandra (often as part of the broader adaptogen protocol including Eleuthero and Rhodiola) was a modest but reproducible performance-enhancement aid for endurance and recovery, without the cardiovascular and central-nervous-system stimulant effects of caffeine and without doping-control concerns. Soviet national teams in cross-country skiing, weightlifting, wrestling, and rowing routinely incorporated adaptogen supplementation into their training programs.
Lactate Reduction and Mitochondrial Function
The most consistent and biochemically interpretable finding in the Schisandra endurance literature is reduction in blood lactate accumulation at standardized submaximal exercise workloads. Lactate is produced by anaerobic glycolysis in skeletal muscle when oxidative phosphorylation cannot meet adenosine triphosphate (ATP) demand; lactate accumulation correlates with the perceived effort of sustained exercise and with the limit of exercise duration.
Three mechanisms are proposed for how Schisandra reduces lactate accumulation:
- Improved mitochondrial function — the same mitochondrial-stabilization effect documented in hepatic and neuronal tissue operates in skeletal muscle mitochondria. Schisandrin B preserves mitochondrial inner membrane integrity, prevents the mitochondrial permeability transition under metabolic stress, and supports oxidative phosphorylation efficiency. The net effect is that more of the muscle's adenosine triphosphate production proceeds through oxidative pathways rather than reverting to anaerobic glycolysis
- Glycogen-sparing effect — Schisandra appears to shift substrate utilization toward fatty acid oxidation, sparing muscle glycogen for later in the exercise bout. This delays the glycogen depletion point and the consequent shift to anaerobic metabolism
- Improved lactate clearance — in addition to reducing lactate production, Schisandra may improve hepatic and renal lactate clearance, accelerating the return to baseline lactate concentrations after exercise. The mechanism likely involves the broader hepatic-function support documented in the Liver Protection deep-dive (the liver is the principal site of lactate-to-glucose conversion via gluconeogenesis through the Cori cycle)
The integrated effect, as the Soviet reports describe it: a trained athlete consuming Schisandra extract before exercise accumulates less blood lactate at any given workload, perceives the exercise as easier, sustains a given workload longer, and recovers lactate clearance more rapidly after exercise. The effect sizes these reports give are modest (15-30% lactate reduction at standardized workloads) but described as operationally meaningful in endurance sports where lactate accumulation is the limiting factor.
What the 2008 Panossian and Wikman Review Reports
The 2008 review by Panossian and Wikman in the Journal of Ethnopharmacology is an English-language overview of Russian research on Schisandra chinensis. Its summary reports that:
- Schisandra gained recognition as an adaptogen in the official medicine of the USSR in the early 1960s, mainly because of the many pharmacological and clinical studies Russian scientists carried out in the two decades before
- In animal studies, Schizandra increased physical working capacity and protected against a broad range of harmful factors, including heat shock, skin burns, cooling, frostbite, immobilisation and swimming under load in air at lowered pressure
- In healthy people, Schizandra “increases endurance and accuracy of movement, mental performance and working capacity,” and changes the resting levels of nitric oxide and cortisol in blood and saliva
- Clinical trials in the former USSR reported benefit in asthenia (lasting weakness and exhaustion), in impaired visual function and in a long list of other conditions
The review's summary gives no trial design and no effect sizes for the exercise findings. A later trial of a fixed adaptogen combination of Schisandra, Rhodiola and Eleuthero extracts (Aslanyan and colleagues, 2010, with Panossian and Wikman among the authors) gave a single 270 mg tablet to 20 of 40 healthy women aged 20-68 who reported long-term stress, and a placebo tablet to the other 20. Two hours later the women given the combination scored better than the placebo group on the d2 test of attention, speed and accuracy (p<0.05). That trial measured mental performance only, not exercise.
In the adaptogen concept, a combined “preserve performance under stress” effect across both physical and mental tasks is what distinguishes adaptogens from pure stimulants (caffeine, methylphenidate) which can improve cognitive performance while depleting reserves, and from pure ergogenic aids (creatine, sodium bicarbonate) which improve physical performance without cognitive support.
Creatine Kinase and Skeletal Muscle Damage Markers
One of the more clinically interpretable Soviet findings was reduction in post-exercise creatine kinase (CK) elevation, an indicator of skeletal muscle membrane damage from eccentric or high-intensity exercise. Post-exercise creatine kinase elevation peaks at 24-48 hours after damaging exercise and correlates with delayed-onset muscle soreness (DOMS) and impairment of subsequent training quality.
Soviet reports describe a 20-40% smaller 24-48 hour creatine kinase peak when Schisandra extract was given before and after high-intensity training; the trials behind this figure could not be traced. In a placebo-controlled study in sport horses with poor performance and high blood levels of liver enzymes and creatine phosphokinase (CPK), 14 days of a standardized Schisandra chinensis fruit extract lowered the liver enzymes, and the CPK levels were also lower at day 7 and day 14. The proposed mechanism combines:
- Reduction in exercise-induced oxidative stress (Nrf2 / glutathione mechanism) limiting membrane lipid peroxidation
- Stabilization of mitochondrial membrane preventing calcium-overload-mediated membrane damage
- Anti-inflammatory effects reducing the secondary inflammatory injury that amplifies primary mechanical muscle damage
- Acceleration of glycogen resynthesis allowing faster recovery of metabolic capacity
The practical implication for training programs is that Schisandra may allow higher weekly training volume (more sessions of equivalent intensity per week) by accelerating recovery from individual training sessions. This is the operational basis of the historical Soviet adoption of adaptogen supplementation for national-team athletes — the goal was not to make any single training session more productive but to permit more training sessions per week, allowing larger cumulative training stimulus over a competitive season.
Cortisol-to-Testosterone Ratio and Anabolic Recovery
The cortisol-to-testosterone ratio (C/T ratio) is a widely used marker of training stress balance in sport science. During heavy training, cortisol rises (reflecting catabolic stress) and free testosterone falls (reflecting reduced anabolic drive). A persistently elevated cortisol-to-testosterone ratio is associated with overtraining syndrome, plateauing or declining performance, and increased injury risk.
Schisandra appears to favorably modulate the cortisol-testosterone balance during heavy training. The cortisol modulation has been discussed in the Adaptogenic and Stress deep-dive — reduction of cortisol overshoot during acute and chronic stress. The testosterone effect is less well-characterized but appears to involve preservation of testicular function under chronic stress load (reduction of stress-induced hypogonadism) rather than direct androgenic action. Schisandra does not appear to function as a direct androgen, and there is no evidence of testosterone elevation in healthy unstressed subjects.
The clinical relevance for athletes is real but modest. Schisandra is not anabolic in the sense of anabolic-androgenic steroids and will not produce supraphysiological testosterone elevation. It does appear to support normal testosterone production under conditions of heavy training stress that would otherwise suppress it, contributing to preserved recovery and adaptation. This is consistent with the broader adaptogenic Lazarev definition of "normalizing rather than stimulating" function.
Schisandra does not appear on any of the standard doping-control prohibited-substance lists (WADA, IOC, NCAA) and is permitted for athletic use; governing bodies hold the current lists, and contamination of supplements with prohibited substances is a known risk for athletes subject to doping control.
VO2 Max, Work Capacity, and Time-to-Exhaustion
Three performance measures for which Soviet reports describe Schisandra effects in trained subjects:
- VO2 max — the maximal rate of oxygen utilization during graded exercise, the gold-standard measure of cardiovascular and metabolic endurance capacity. Soviet reports describe 3-7% improvements in VO2 max after 4-8 weeks of Schisandra supplementation in trained endurance athletes — a meaningful effect in a population where annual VO2 max improvement from training alone is typically 1-2% in already-trained subjects
- Work capacity at fixed lactate threshold — the workload sustainable at the blood lactate threshold (typically 4 mmol/L) is reported to improve by 10-15% in Schisandra-supplemented athletes, reflecting both the lactate-clearance improvement and the mitochondrial-function preservation
- Time-to-exhaustion at fixed workload — perhaps the most operationally relevant measure for endurance sport. At workloads corresponding to roughly 75% of VO2 max, time-to-exhaustion is reported to improve by 10-20% in Schisandra-supplemented athletes
These are modest improvements in absolute terms, described as operationally meaningful at the competitive level and substantial when accumulated across a competitive season. The reported effects are most pronounced in endurance-dominant disciplines (cross-country skiing, long-distance running, cycling, rowing, swimming) and less pronounced in power-dominant disciplines (sprinting, weightlifting, throwing events) where the limiting factor is maximal single-burst power rather than sustained metabolic capacity.
Contemporary Applications for Athletes and Active Adults
How athletes, coaches and practitioners apply the Schisandra endurance literature today:
- Recreational endurance athletes (cycling, running, triathlon) — practitioners describe 4-8 week courses of a standardized extract during heavy training blocks, 100-500 mg of standardized lignan extract twice daily, in the morning and after training, stopped 1-2 weeks before competition to see unsupplemented baseline performance. The two modern placebo-controlled trials used 1,000 mg (1 g) of extract a day for 12 weeks
- Recovery support during high-volume training — practitioners describe its use during base-building phases with high weekly training volume, where the limiting factor is cumulative recovery rather than single-session performance
- Masters athletes (40+ years) — practitioners describe older athletes, who recover more slowly, as a group that may gain most from adaptogenic recovery support, because the underlying physiology of slower recovery overlaps mechanistically with the targets of adaptogen action (mitochondrial efficiency, antioxidant capacity, hypothalamic-pituitary-adrenal-axis recovery). In a 2021 trial in adults over 50 who walked regularly, knee strength rose more with Schisandra extract than with placebo, while muscle mass did not differ
- Adjunct during return-to-training after illness — the 2008 review lists asthenia (lasting weakness and exhaustion) among the conditions in which Soviet clinical trials reported benefit; practitioners extend this to the reduced training tolerance that often persists for several weeks after a viral illness
- Military and tactical-athlete contexts — sustained-operations performance under sleep deprivation and chronic stress; this is the original Soviet military application and remains relevant for contemporary special operations and tactical training contexts
Because the reported effects are modest, practitioners describe judging Schisandra by individual response: a 4-8 week course with performance tests before and after (whatever measure fits the sport — functional threshold power (FTP) for cyclists, 5K time for runners, maximum-repetition tests for strength athletes). Population-averaged trial results may not reflect any one person's response.
Cautions and Practical Dosing for Athletic Use
- Drug interactions through the cytochrome P450 3A (CYP3A) enzymes — the dominant safety concern, also discussed in the Liver Protection deep-dive. In 12 healthy men, 13 days of an extract of a related species, Schisandra sphenanthera, raised blood exposure (AUC) to the transplant drug tacrolimus by 164.2% on average and its peak blood level by 227.1%, and cut its clearance by 49.0%. Tacrolimus is broken down mainly by the CYP3A enzymes, so the finding points to higher blood levels of drugs cleared this way while the herb is taken
- Doping-control status — Schisandra is not currently on the WADA, IOC, NCAA, or USADA prohibited-substance lists, but governing bodies hold the current lists, and supplements can be contaminated with prohibited substances; third-party sport-testing programmes batch-test products for banned substances
- Pre-competition discontinuation — many practitioners recommend discontinuing Schisandra 1-2 weeks before major competition to assess unsupplemented baseline performance and to avoid any unforeseen interaction with competition-related stress responses
- Heart rate variability monitoring — for endurance athletes tracking HRV-based training load, Schisandra may modify baseline HRV and shift the interpretation of training-stress markers, so HRV baselines taken before starting or after stopping Schisandra may not be comparable
- Dose timing — practitioners describe morning and post-training doses, because evening doses may interfere with falling asleep through mild central nervous system-stimulant effects
- Adjunct only, not substitute — Schisandra does not substitute for the fundamentals of training: appropriate periodization, adequate sleep, adequate nutrition (sufficient carbohydrate, protein, and micronutrients), and recovery modalities
- Quality control — whole-fruit powder products vary dramatically in lignan content, while standardized extracts report their lignan content
- Cycling rather than continuous use — general adaptogen practice uses 6-12 week blocks of supplementation with planned breaks rather than indefinite continuous use; long-term human safety data are lacking
Modern Placebo-Controlled Trials in People
Two randomized, double-blind, placebo-controlled trials from Korea have tested Schisandra chinensis extract in people over 12 weeks. Both measured leg strength:
- Park and colleagues, 2020 — 45 healthy post-menopausal women (average age 61.9 years) took 1,000 mg of Schisandra extract (24 women) or 1,000 mg of starch (21 women) a day for 12 weeks. Thigh (quadriceps) muscle strength rose and blood lactate at rest fell in the Schisandra group; muscle mass and the other measures did not change differently between the groups.
- Cho and colleagues, 2021 — 54 adults over 50 with relatively low muscle mass, all of whom walked 30-60 minutes a day on more than 3 days a week, took 1 g of Schisandra extract or a placebo a day for 12 weeks. Knee-extension strength rose more with the extract than with placebo: by 10.2 newton-metres (Nm, a measure of turning force) more in the right leg and 6.7 Nm more in the left. Muscle mass, inflammation and antioxidant markers and quality-of-life scores did not differ between the groups, and none of the participants had an adverse event.
Key Research Papers
- Panossian A, Wikman G (2008). Pharmacology of Schisandra chinensis Bail.: An overview of Russian research and uses in medicine. Journal of Ethnopharmacology 118(2):183-212. — PubMed PMID: 18515024
- Panossian A, Wikman G (2009). Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Current Clinical Pharmacology 4(3):198-219. — PubMed PMID: 19500070
- Hancke J, Burgos R, Cáceres D, Brunetti F, Durigon A, Wikman G (1996). Reduction of serum hepatic transaminases and CPK in sport horses with poor performance treated with a standardized Schizandra chinensis fruit extract. Phytomedicine 3(3):237-240. — PubMed PMID: 23195076
- Ahumada F, Hermosilla J, Hola R, Peña R, Wittwer F, Wegmann E, Hancke J, Wikman G (1989). Studies on the effect of Schizandra chinensis extract on horses submitted to exercise and maximum effort. Phytotherapy Research 3(5):175-179. — doi:10.1002/ptr.2650030504
- Park J, Han S, Park H (2020). Effect of Schisandra Chinensis Extract Supplementation on Quadriceps Muscle Strength and Fatigue in Adult Women: A Randomized, Double-Blind, Placebo-Controlled Trial. International Journal of Environmental Research and Public Health 17(7):2475. — PubMed PMID: 32260466
- Cho YH, Lee SY, Lee CH, Park JH, So YS (2021). Effect of Schisandra chinensis Baillon extracts and regular low-intensity exercise on muscle strength and mass in older adults: a randomized, double-blind, placebo-controlled trial. American Journal of Clinical Nutrition 113(6):1440-1446. — PubMed PMID: 33710261
- Panossian AG, Oganessian AS, Ambartsumian M, Gabrielian ES, Wagner H, Wikman G (1999). Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva. Phytomedicine 6(1):17-26. — PubMed PMID: 10228607
- Panossian A, Wikman G, Kaur P, Asea A (2009). Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine. — PubMed PMID: 19188053
- Aslanyan G, Amroyan E, Gabrielyan E, Nylander M, Wikman G, Panossian A (2010). Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomedicine 17(7):494-499. — PubMed PMID: 20374974
- Brekhman II, Dardymov IV (1969). New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology 9:419-430. — PubMed PMID: 4892434
- Kim KJ, Yoon KY, Hong HD, Lee BY (2012). Schisandra chinensis prevents hepatic lipid peroxidation and oxidative stress in rats subjected to heat environmental stress. Phytotherapy Research 26(11):1674-1680. — PubMed PMID: 22389228
- Xin HW, Wu XC, Li Q, Yu AR, Zhu M, Shen Y, Su D, Xiong L (2007). Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers. British Journal of Clinical Pharmacology 64(4):469-475. — PubMed PMID: 17506780
- Wagner H, Norr H, Winterhoff H (1994). Plant adaptogens. Phytomedicine 1(1):63-76. — PubMed PMID: 23195818